Insight towards therapeutic susceptibility of KRAS-mutant cancers from MRTX1257, a novel KRAS G12C mutant-selective small-molecule inhibitor.

被引：0
|
作者：
Christensen, James G. [1 ]
机构：
[1] Mirati Therapeut, San Diego, CA USA
来源：
MOLECULAR CANCER RESEARCH | 2020年 / 18卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA19
引用
收藏
页码：24 / 24
页数：1
相关论文
共 32 条
  • [21] Discovery and characterization of ABSK071, a novel and potent small-molecule covalent inhibitor for KRAS-G12C
    Guo, F.
    Zhao, Y.
    Yu, H.
    Xu, Y.
    Chen, Z.
    Yang, S.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S22 - S23
  • [22] Therapeutic vulnerabilities among KRAS G12C mutant (mut) advanced cancers based on co-alteration (co-alt) patterns.
    Nusrat, Maliha
    Roszik, Jason
    Holla, Vijaykumar
    Cai, Tiantian
    Hong, Meiyue
    Coker, Oluwadara
    Johnson, Benny
    Ahnert, Jordi Rodon
    Janku, Filip
    Kopetz, Scott
    Shaw, Kenna Rael
    Meric-Bernstam, Funda
    Hong, David S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [23] Dual RAF/MEK Inhibitor VS-6766 for Treatment of KRAS Mutant NSCLC: Novel Combinations Targeting G12C or G12V Variants
    Coma, S.
    Chowdhury, S.
    Musteanu, M.
    Stewart, A.
    Pickard, L.
    Krebs, M.
    Minchom, A.
    Banerji, U.
    Barbacid, M.
    Pachter, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1124 - S1124
  • [24] HM99462, a Novel & potent SOS1 inhibitor, induces tumor regressions in combination with KRAS G12C inhibitor, MEK inhibitor, or EGFR mutant inhibitor
    Choi, Jaeyul
    Jumg, Seung Hyun
    Park, Wongi
    Byun, Jooyun
    Lim, Semi
    Lee, Youngjoo
    Jeon, Soye
    Kim, Yu-Yon
    Ahn, Young Gil
    Kim, Young Hoon
    Suh, Kwee Hyun
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [25] AMG 510, a novel small molecule inhibitor of KRAS(G12C), for patients (pts) with advanced gastrointestinal (GI) cancers: Results from the CodeBreaK100 phase I trial
    Strickler, J. H.
    Fakih, M.
    Price, T. J.
    Desai, J.
    Durm, G.
    Krauss, J. C.
    Kuboki, Y.
    Kim, T. W.
    Sacher, A.
    Henary, H.
    Kim, J.
    Hong, D. S.
    ANNALS OF ONCOLOGY, 2020, 31 : S1274 - S1275
  • [26] Sotorasib GTPase KRAS (G12C mutant) inhibitor Treatment of non-small cell lung cancer Treatment of colorectal cancer Treatment of solid tumors
    Gras, J.
    DRUGS OF THE FUTURE, 2021, 46 (07) : 521 - 528
  • [27] MEK Inhibitor Combined with RTK Inhibitor (Trametinib Plus Anlotinib) In Non-g12c KRAS-Mutant Non-Small Cell Lung Cancer: A New Strategy
    Han, B.
    Lu, J.
    Zhong, H.
    Chu, T.
    Zhang, W.
    Hu, M.
    Shi, C.
    Xiong, L.
    Gu, A.
    Wang, H.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S351 - S351
  • [28] MEK inhibitor combined with RTK inhibitor (trametinib plus anlotinib) in non-G12C KRAS-mutant non-small cell lung cancer: A new strategy
    Han, Baohui
    Lu, Jun
    Zhong, Hua
    Chu, Tianqing
    Zhang, Wei
    Hu, Minjuan
    Shi, Chunlei
    Xiong, Liwen
    Gu, Aiqin
    Wang, Huimin
    Lou, Yuqing
    Zhang, Yanwei
    Zhong, Runbo
    Gao, Zhiqiang
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [29] A phase 1/2 study of VS-6766 (RAF/MEK clamp) in combination with sotorasib (G12C inhibitor) in patients with KRAS G12C mutant non-small cell lung cancer (NSCLC) (RAMP 203).
    Govindan, Ramaswamy
    Awad, Mark M.
    Gadgeel, Shirish M.
    Pachter, Jonathan A.
    Patrick, Gloria
    Denis, Louis J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [30] LKB1 loss rewires JNK-induced apoptotic protein dynamics through NUAKs and sensitizes KRAS-mutant non-small cell lung cancers to combined KRAS G12C+MCL-1 blockade
    Li, Chendi
    Syed, Mohammed Usman
    Shen, Yi
    Oh, Audris
    Fraser, Cameron
    Kreuzer, Johannes
    Nabel, Christopher
    Webster, Kaitlyn
    Morris, Robert
    Caenepeel, Sean
    Saiki, Anne Y.
    Rex, Karen
    Lipford, J. Russell
    Hass, Wilhelm
    Sarosiek, Kristopher
    Hughes, Paul E.
    Hata, Aaron
    CANCER RESEARCH, 2022, 82 (12)
1234